Bharat Biotech Launches Nucelion For Advanced Therapies
Vaccine maker Bharat Biotech has launched Nucleon Therapeutics, a wholly-owned CRDMO focused on cell and gene therapies. The new venture marks its strategic expansion into next-generation therapeutic solutions. Nucleon will support global innovators with scalable development and manufacturing for treatments targeting cancers, autoimmune diseases.